NCT00793741View on ClinicalTrials.gov

Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Type 1 DiabetesHypoglycemia Unawareness
Interventions
DRUG

somatostatin

Somatostatin may be used to suppress endogenous insulin secretion

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT00793741 - Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness | Biotech Hunter | Biotech Hunter